×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Laboratory Automation Market

ID: MRFR/HC/48307-HCR
200 Pages
Rahul Gotadki
October 2025

China Laboratory Automation Market Research Report By Application (Sample Preparation, Liquid Handling, Automated Workflow, Data Management, Analysis and Testing), By Product Type (Automated Workstations, Robotic Systems, Software, Consumables, Analyzers) and By End Use (Pharmaceuticals, Biotechnology, Clinical Laboratories, Academic Research, Environmental Testing)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Laboratory Automation Market Infographic
Purchase Options

China Laboratory Automation Market Summary

As per MRFR analysis, the China Laboratory Automation Market Size was estimated at 399.75 USD Million in 2024. The China laboratory automation market is projected to grow from 423.3 USD Million in 2025 to 750.23 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.89% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The China laboratory automation market is experiencing robust growth driven by technological advancements and increasing demand for efficiency.

  • The market is witnessing increased investment in automation technologies, particularly in the pharmaceutical and biotechnology segments.
  • Integration of AI and machine learning is becoming prevalent, enhancing data analysis and operational efficiency.
  • The largest segment is high-throughput screening, while the fastest-growing segment is personalized medicine.
  • Key market drivers include rising demand for high-throughput screening and advancements in robotics and automation.

Market Size & Forecast

2024 Market Size 399.75 (USD Million)
2035 Market Size 750.23 (USD Million)

Major Players

Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Beckman Coulter (US), Eppendorf (DE), Tecan Group (CH), Hamilton Company (US), Roche Diagnostics (CH)

China Laboratory Automation Market Trends

The The laboratory automation sector is experiencing notable growth. is experiencing notable growth, driven by advancements in technology and increasing demand for efficiency in research and clinical settings. Automation solutions are becoming essential for laboratories aiming to enhance productivity, reduce human error, and streamline workflows. In China, the emphasis on innovation and modernization in the healthcare sector is propelling the adoption of automated systems. This trend is further supported by government initiatives aimed at improving laboratory infrastructure and promoting research and development. As a result, laboratories are increasingly investing in automation technologies to meet the rising expectations for accuracy and speed in testing and analysis. Moreover, the integration of artificial intelligence and machine learning into laboratory automation systems is transforming traditional practices. These technologies enable laboratories to analyze vast amounts of data more effectively, leading to improved decision-making and outcomes. The growing focus on personalized medicine and precision diagnostics in China is also contributing to the expansion of the laboratory automation market. As laboratories seek to adapt to these evolving demands, the implementation of automated solutions is likely to become a standard practice, ensuring that they remain competitive in a rapidly changing environment.

Increased Investment in Automation Technologies

Laboratories are allocating more resources towards automation technologies to enhance operational efficiency. This trend reflects a broader commitment to modernizing laboratory practices, which is essential for meeting the growing demands of research and clinical applications.

Integration of AI and Machine Learning

The incorporation of artificial intelligence and machine learning into laboratory automation systems is reshaping workflows. These technologies facilitate data analysis and improve accuracy, thereby supporting laboratories in achieving better results and optimizing processes.

Focus on Regulatory Compliance and Quality Control

As laboratories strive to maintain high standards, there is a heightened emphasis on regulatory compliance and quality control. Automation solutions are increasingly viewed as vital tools for ensuring adherence to regulations and enhancing the reliability of laboratory results.

China Laboratory Automation Market Drivers

Growing Focus on Personalized Medicine

The laboratory automation market in China is increasingly influenced by the growing focus on personalized medicine. As healthcare shifts towards more tailored treatment approaches, laboratories are required to conduct more complex analyses and tests. This shift necessitates the implementation of advanced automation technologies to manage the increased workload efficiently. The demand for automation solutions that can handle diverse sample types and provide rapid results is likely to rise. In 2025, the market for personalized medicine is expected to expand significantly, with estimates suggesting a growth rate of approximately 18%. This trend indicates that laboratories must invest in automation to keep pace with the evolving landscape of personalized healthcare.

Advancements in Robotics and Automation

Technological advancements in robotics are significantly influencing the laboratory automation market in China. The integration of sophisticated robotic systems allows for improved precision and efficiency in laboratory processes. These innovations facilitate tasks such as sample handling, liquid dispensing, and data analysis, which are crucial for maintaining high standards in research and diagnostics. In recent years, the market has seen a shift towards more versatile and user-friendly robotic platforms, which can be easily integrated into existing laboratory workflows. As a result, the adoption rate of robotic automation is expected to increase, with projections indicating a growth of around 20% in the next few years. This trend underscores the importance of robotics in enhancing laboratory productivity and accuracy.

Emphasis on Data Management and Integration

The laboratory automation market in China is increasingly characterized by an emphasis on data management and integration. As laboratories generate vast amounts of data, the need for effective data handling solutions becomes paramount. Automation technologies that facilitate seamless data integration and management are essential for ensuring compliance with regulatory standards and enhancing operational efficiency. The rise of digital laboratory solutions, which combine automation with advanced data analytics, is expected to drive growth in this sector. In 2025, the market for data management solutions in laboratories is anticipated to grow by approximately 14%, reflecting the critical role of data in modern laboratory practices. This trend highlights the necessity for laboratories to adopt integrated automation systems that can support comprehensive data management.

Rising Demand for High-Throughput Screening

The The market for laboratory automation in China is experiencing a notable surge. in China is experiencing a notable surge in demand for high-throughput screening technologies. This trend is primarily driven by the increasing need for rapid and efficient testing in various sectors, including pharmaceuticals and biotechnology. As research institutions and companies strive to enhance productivity, the adoption of automated systems that can process large volumes of samples simultaneously becomes essential. In 2025, the market for high-throughput screening is projected to grow by approximately 15%, reflecting the urgency for faster results in drug discovery and development. Consequently, this rising demand is likely to propel investments in laboratory automation solutions, thereby shaping the future landscape of the laboratory automation market.

Increased Funding for Research and Development

In China, the laboratory automation market is benefiting from increased funding for research and development initiatives. Government and private sector investments are being directed towards enhancing laboratory capabilities, which includes the adoption of automation technologies. This influx of capital is aimed at fostering innovation and improving the efficiency of research processes. As funding continues to rise, laboratories are more likely to invest in automated systems that streamline operations and reduce human error. Reports indicate that R&D funding in the life sciences sector is projected to grow by 12% annually, which will likely bolster the laboratory automation market as institutions seek to modernize their facilities and improve research outcomes.

Market Segment Insights

By Application: Sample Preparation (Largest) vs. Liquid Handling (Fastest-Growing)

In the China In the China laboratory automation sector, Sample Preparation holds the largest market share., Sample Preparation holds the largest market share due to its foundational role in various laboratory processes. This segment is crucial for ensuring that samples are ready for analysis, making it indispensable across multiple applications. Liquid Handling follows, gaining significant traction as automated solutions streamline workflow and improve accuracy in sample management. The growth trends in the China laboratory automation market point towards rapid advancements in Liquid Handling technology, driven by the demand for efficiency and accuracy in scientific research. As laboratories aim to enhance productivity, automated workflows are becoming increasingly prevalent, with a notable rise in Data Management solutions contributing to this trend by ensuring better data integrity and accessibility for researchers.

Sample Preparation (Dominant) vs. Automated Workflow (Emerging)

Sample Preparation is a dominant segment characterized by its critical role in laboratory processes, providing essential techniques that ensure samples are correctly managed and prepared for subsequent analysis. It encompasses various methods and technologies designed to minimize errors and optimize results. On the other hand, Automated Workflow is an emerging segment that is gaining popularity for its ability to integrate multiple laboratory processes into a seamless operation, significantly enhancing efficiency. This segment focuses on reducing manual intervention through advanced robotics and software solutions, ultimately leading to faster and more precise results, thus catering to the increasing complexity of modern laboratory requirements.

By Product Type: Automated Workstations (Largest) vs. Robotic Systems (Fastest-Growing)

In the China laboratory automation market, the segment values display a diverse landscape, with automated workstations commanding the largest share. They are pivotal for streamlining laboratory processes, enhancing efficiency, and reducing human error. On the other hand, robotic systems have emerged as a dynamic segment, showing impressive growth due to their ability to handle complex tasks and improve throughput in laboratory settings. Growth trends in the segment reflect the ongoing technological advancements and increasing demand for high-throughput solutions. The rise of AI and machine learning in laboratory systems fuels the adoption of robotic systems, driving their rapid emergence. Additionally, the requirement for higher accuracy and efficiency continues to push laboratories toward automation, favoring software and consumables as integral components to support these systems.

Automated Workstations (Dominant) vs. Robotic Systems (Emerging)

Automated workstations serve as the backbone of laboratory automation, characterized by their versatility to perform various tasks from sample processing to data analysis. These systems minimize manual intervention, ensuring consistent results and efficient workflow management. Conversely, robotic systems are rapidly gaining traction as an emerging technology, engineered for precision and speed in handling intricate laboratory tasks. Their capability to operate alongside AI-driven software enhances their effectiveness, making them indispensable in modern laboratories. The synergy between these two segments indicates a robust growth trajectory, driven by the need for enhanced laboratory efficiency and innovation in automation technology.

By End-Use: Pharmaceuticals (Largest) vs. Biotechnology (Fastest-Growing)

In the China laboratory automation market, the end-use segment distribution showcases a strong dominance of the pharmaceuticals sector, which significantly influences the overall market dynamics. This sector not only holds the largest share but also drives innovation and investment in automation technologies, reflecting the growing need for improved efficiency and accuracy in drug development and production. Following closely is the biotechnology sector, which, albeit smaller in market share, is rapidly expanding due to advancements in research and development and increasing investments in biological research. The growth trends within the end-use segments underscore the emerging prominence of biotechnology, fueled by advancements in genomics and personalized medicine. Clinical laboratories are also seeing a notable rise as healthcare demands grow, necessitating more sophisticated automation solutions for diagnostics. Additionally, environmental testing is gaining traction due to tightening regulations and the increasing focus on sustainable practices, while academic research continues to benefit from government funding and collaboration between institutions and industry, enhancing its relevance in laboratory automation.

Pharmaceuticals (Dominant) vs. Biotechnology (Emerging)

The pharmaceuticals segment is characterized by its rigorous standards and significant investment in automation technologies, which streamline complex laboratory processes and enhance productivity. This segment showcases a strong need for automation in high-throughput screening, data management, and regulatory compliance, making it a vital area for innovation. Conversely, the biotechnology sector, while emerging, is rapidly evolving with an increased focus on personalized medicine and biomanufacturing. This sector is attracting attention for its potential in novel therapies and diagnostics, leading to higher funding and infrastructure developments. Both segments, though distinct, are crucial for advancing laboratory automation technologies, thus positioning them as key players within the China laboratory automation market.

Get more detailed insights about China Laboratory Automation Market

Key Players and Competitive Insights

The laboratory automation market in China is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for efficiency in laboratory processes. Key players such as Thermo Fisher Scientific (US), Abbott Laboratories (US), and Agilent Technologies (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Thermo Fisher Scientific (US) focuses on innovation through the development of integrated laboratory solutions, while Abbott Laboratories (US) emphasizes strategic partnerships to expand its product offerings. Agilent Technologies (US) is leveraging digital transformation to optimize its operations, thereby enhancing customer engagement and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological innovation and customer-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach not only mitigates risks associated with global supply chains but also aligns with the growing trend of sustainability in manufacturing practices. The market structure appears moderately fragmented, with several key players exerting influence over various segments. The collective actions of these companies suggest a shift towards a more integrated and collaborative market environment, where partnerships and alliances play a crucial role in driving growth.

In October 2025, Thermo Fisher Scientific (US) announced the launch of a new automated liquid handling system designed to enhance throughput and accuracy in laboratory workflows. This strategic move is significant as it positions the company to meet the increasing demand for high-throughput solutions in research and clinical laboratories, thereby reinforcing its competitive edge in the market. The introduction of this technology is likely to attract a broader customer base seeking efficiency and precision in their laboratory operations.

In September 2025, Abbott Laboratories (US) entered into a collaboration with a leading Chinese biotechnology firm to develop advanced diagnostic automation solutions. This partnership is indicative of Abbott's strategy to penetrate the rapidly growing Chinese market, leveraging local expertise to tailor solutions that meet specific regional needs. Such collaborations may enhance Abbott's market share and foster innovation in diagnostic technologies, aligning with the broader trend of localized solutions in the industry.

In August 2025, Agilent Technologies (US) unveiled a new cloud-based platform aimed at integrating laboratory data management with automation systems. This initiative reflects Agilent's commitment to digital transformation, enabling laboratories to streamline operations and improve data accessibility. The strategic importance of this development lies in its potential to enhance operational efficiency and facilitate data-driven decision-making, which is increasingly vital in modern laboratory environments.

As of November 2025, current competitive trends in the laboratory automation market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into laboratory processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to deliver customized solutions. This shift underscores the importance of agility and responsiveness in a rapidly changing market landscape.

Key Companies in the China Laboratory Automation Market market include

Industry Developments

The China Laboratory Automation Market has been experiencing significant advancements, with companies like Thermo Fisher Scientific and Agilent Technologies actively expanding their footprints in the region. Recent developments in October 2023 revealed an increase in market valuations attributed to heightened demand for automation solutions amidst growing investments in healthcare and biotechnology sectors. The consolidation trend continues, as evidenced by the rising interest in mergers and acquisitions. Notably, in June 2023, Becton Dickinson announced its acquisition of a smaller diagnostics firm specializes in automation technology, aiming to enhance its portfolio in laboratory automation. 

Additionally, Sartorius AG expanded operations in China, focusing on bioprocessing and laboratory automation solutions, while Hudson Robotics and Labcyte reported increased collaborations with Chinese research institutions to improve R&D efficiency. In the past 2-3 years, initiatives taken by the Chinese government to boost biotechnology innovation have fostered a conducive environment for laboratory automation growth. The integration of artificial intelligence in laboratory systems is rising, with companies like PerkinElmer and Beckman Coulter leading innovations. Overall, the landscape of the China Laboratory Automation Market is evolving, driven by technological advancements and strategic partnerships among leading firms.

Future Outlook

China Laboratory Automation Market Future Outlook

The Laboratory Automation Market in China is projected to grow at a 5.89% CAGR from 2024 to 2035, driven by technological advancements and increasing demand for efficiency.

New opportunities lie in:

  • Integration of AI-driven robotic systems for enhanced precision
  • Development of modular automation solutions for diverse laboratory needs
  • Expansion of cloud-based data management platforms for real-time analytics

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased automation adoption.

Market Segmentation

China Laboratory Automation Market End-Use Outlook

  • Pharmaceuticals
  • Biotechnology
  • Clinical Laboratories
  • Academic Research
  • Environmental Testing

China Laboratory Automation Market Application Outlook

  • Sample Preparation
  • Liquid Handling
  • Automated Workflow
  • Data Management
  • Analysis and Testing

China Laboratory Automation Market Product Type Outlook

  • Automated Workstations
  • Robotic Systems
  • Software
  • Consumables
  • Analyzers

Report Scope

MARKET SIZE 2024 399.75(USD Million)
MARKET SIZE 2025 423.3(USD Million)
MARKET SIZE 2035 750.23(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.89% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Thermo Fisher Scientific (US), Abbott Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Beckman Coulter (US), Eppendorf (DE), Tecan Group (CH), Hamilton Company (US), Roche Diagnostics (CH)
Segments Covered Application, Product Type, End-Use
Key Market Opportunities Integration of artificial intelligence in laboratory automation enhances efficiency and accuracy in research processes.
Key Market Dynamics Rising demand for precision and efficiency drives innovation in laboratory automation technologies across various sectors.
Countries Covered China

Leave a Comment

FAQs

What is the current market size of the China Laboratory Automation Market in 2024?

The China Laboratory Automation Market is expected to be valued at 500.0 USD Million in 2024.

What is the projected market value for the China Laboratory Automation Market by 2035?

The overall market is anticipated to reach 1500.0 USD Million by 2035.

What is the expected CAGR for the China Laboratory Automation Market from 2025 to 2035?

The market is projected to grow at a CAGR of 10.503% during the forecast period.

Which application segment in the China Laboratory Automation Market will have the highest growth from 2024 to 2035?

The Sample Preparation segment is expected to increase from 120.0 USD Million in 2024 to 360.0 USD Million by 2035.

How large will the Liquid Handling application segment be in the China Laboratory Automation Market by 2035?

The Liquid Handling application is projected to reach 300.0 USD Million by 2035.

Who are the key players in the China Laboratory Automation Market?

Major players include Danaher Corporation, BioRad Laboratories, Hudson Robotics, and Thermo Fisher Scientific among others.

What is the estimated market size for the Automated Workflow application in 2024?

The Automated Workflow segment is valued at 80.0 USD Million in 2024.

What is the value of the Data Management application segment in the market for 2024 and 2035?

Data Management is valued at 90.0 USD Million in 2024 and is expected to grow to 270.0 USD Million by 2035.

What growth opportunities are anticipated in the China Laboratory Automation Market?

The market is expected to benefit from advancements in technology and increased demand for efficient laboratory processes.

What market size will the Analysis and Testing application segment reach by 2035?

The Analysis and Testing segment is projected to grow to 330.0 USD Million by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions